|
V.OML
|
We had a great 2015. We are now in a short term softness, not because the...
|
|
V.OML
|
Hi knicksman, you know, in all respect, you've said in a previous post...
|
|
BLUSD
|
No, this is nothing more than a routine presentation at a biotech get...
|
|
V.OML
|
Is the new contract too small? Is it too late? Or is it that you don't...
|
|
V.OML
|
As I've said in a previous post, based on info in some of last year's...
|
|
V.OML
|
Agree Kulewater. In fact, as they indicated in the March 15 NR, this IR...
|
|
V.OML
|
I am an active investor too, I do trade stocks for short term profits, but...
|
|
V.OML
|
I have a couple of points to answer your post Knicksman: 1) Last year's...
|
|
BLUSD
|
Thanks Ichiban, very interesting indeed! This makes things look even better...
|
|
BLUSD
|
Hello folks, I've invested in this company with only the Kiacta phase 3...
|
|
BLUSD
|
It's all about the outcome from the Kiacta Phase 3 study which is due...
|
|
V.CNO
|
This stock has very little downside risk. The company has just posted its...
|
|
V.OML
|
Selling pressure has subsided and we have good buying support in the 1.50-1...
|
|
V.OML
|
I love the news too. At the same time, the aggressive share buyback continues...
|
|
V.OML
|
A step in the right direction! It is increasingly clear that the outcome from...
|
|
V.OML
|
If you're like me, a shareholder who believes in the long term success of...
|
|
V.OML
|
Check out the MD&A sedar filings of Apr 17 and May 30 2014, in both...
|
|
V.OML
|
Thanks for your input Millton, it is certainly interesting to hear different...
|
|
V.OML
|
We had three press releases this week, most of which are positive news, but...
|
|
V.OML
|
It's been said on this board in the past and I say it again. WE NEED TO...
|